Back to Stocks
Rank #1405OGN
Organon & Co.
$7.52
0.80% (Daily)
Market Cap
$1.96B
Revenue
$6.22B
Rank by MCap
#1405
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ms. Carrie Smith Cox
Headquarters
Jersey City, NJ
About Organon & Co.
Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon, which are daily pills used...
Organon & Co. Price Chart
Loading chart…